A rare condition causing sudden, painless blindness in one eye may be doubled among people taking popular GLP-1 drugs for ...
Understanding why some people see no benefits from potent anti-obesity medications could lead to new therapies and ...
Recent research now shows that a sizable number of Americans have been taking GLP-1s off-label. Scientists at New York University and others examined the medical records of Americans across the ...
A recent study suggests the cardiovascular benefits of GLP-1 drugs may disappear quickly when treatment stops.
The cohosts went back and forth after Al Roker brought up Dreyer’s comment.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." ...
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 ...
Dozens of lawsuits claim the drugs led to vision loss, though evidence is mixed.
FDA inspectors found evidence that the compounding pharmacy was making versions of Eli Lilly’s tirzepatide and Novo’s ...
A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their ...
"Eighty-four percent of households with GLP-1 users visit McDonald's. This is an opportunity," McDonald's USA president Skye ...
Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country's biggest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results